France· FR:61183406
FLECTOREFFIGEL 1 %, gel
A medicinal product containing épolamine de diclofénac, registered in France by IBSA PHARMA SAS.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉPOLAMINE DE DICLOFÉNAC
- Manufacturer
- IBSA PHARMA SAS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 4
- cip1334009277213281 tube(s) aluminium verni de 60 g
- cip1334009277215571 flacon(s) aluminium de 50 g
- cip1334009277217861 flacon(s) aluminium de 100 g
- cip1334009302477091 tube(s) polyéthylène avec applicateur à billes de 100 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e269ff71-3703-4210-a01a-185f3fb3c36d GET /v1/drugs/e269ff71-3703-4210-a01a-185f3fb3c36d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61183406",
"date_amm": "2014-04-17",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ÉPOLAMINE DE DICLOFÉNAC",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gel",
"voies_administration": "cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about épolamine de diclofénac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.